Chemical Identity and Properties

5-(Benzyloxy)-2,4-dichloropyrimidine (SKU: B195781) is a halogenated pyrimidine derivative in which a benzyloxy (–OCH₂Ph) group is installed at the 5-position of a 2,4-dichloropyrimidine scaffold. The compound has the molecular formula C₁₁H₈Cl₂N₂O and a molecular weight of approximately 255.10 g/mol. The benzyloxy group serves a dual purpose: it electronically modulates the reactivity of the two chlorine leaving groups while providing a protecting-group handle that can be removed by hydrogenolysis (Pd/C, H₂) to reveal a free hydroxyl or converted to other oxygen functionalities as required by downstream synthesis.

The two ring chlorines exhibit differential electrophilicity. The C-4 chlorine is generally more reactive toward nucleophilic aromatic substitution (SNAr) due to greater activation by the adjacent ring nitrogen, making sequential mono-substitution feasible under controlled conditions. This selectivity is a key design feature exploited in multi-step synthetic routes targeting unsymmetrical 2,4-disubstituted pyrimidines.

Synthesis and Functionalization Strategies

5-(Benzyloxy)-2,4-dichloropyrimidine is typically prepared from 2,4-dichloropyrimidin-5-ol by O-benzylation using benzyl chloride or benzyl bromide in the presence of a base such as K₂CO₃ or Cs₂CO₃ in a polar aprotic solvent (e.g., DMF or acetonitrile). This route preserves both ring chlorines for subsequent diversification.

Sequential SNAr functionalization: The preferred synthetic strategy exploits the reactivity difference between C-4 and C-2 chlorines. A first nucleophile (amine, thiol, or alkoxide) is introduced at C-4 under mild conditions (0 °C to room temperature), followed by a second, often more forcing SNAr or cross-coupling step at C-2 to install a distinct substituent. This sequential approach enables rapid construction of unsymmetrical 2,4-diaminopyrimidine cores found in many kinase inhibitors.

Transition-metal-catalysed cross-coupling: Both chlorine positions are amenable to Pd-catalysed Suzuki–Miyaura, Buchwald–Hartwig, or Negishi coupling reactions, expanding the range of accessible carbon- and nitrogen-linked products beyond those accessible by SNAr alone.

Benzyl deprotection: After core elaboration, the benzyloxy group is routinely removed by catalytic hydrogenolysis (10% Pd/C, H₂, EtOH or EtOAc) to give the corresponding 5-hydroxypyrimidine, which may be further manipulated.

Applications in Medicinal Chemistry

The 2,4-dichloropyrimidine motif is a privileged scaffold in drug discovery, appearing in numerous approved and investigational kinase inhibitors, antiviral agents, and antimicrobial compounds. The 5-benzyloxy substitution further modulates the electronic properties of the ring, influencing binding affinity and selectivity in structure–activity relationship (SAR) studies.

Common target classes where 2,4-disubstituted pyrimidine cores are exploited include:

• Protein kinase inhibitors: PI3K, mTOR, CDK, and EGFR family inhibitors frequently employ 2,4-diaminopyrimidine pharmacophores accessible from this building block.
• Antiviral agents: Pyrimidine-based scaffolds appear in inhibitors targeting viral polymerases and proteases.
• Antimicrobial compounds: Diaminopyrimidines have historical precedent as DHFR inhibitors (e.g., trimethoprim analogues).

The benzyloxy group at C-5 can mimic or serve as a precursor to phenoxy or hydroxyl pharmacophoric elements, making B195781 a valuable reagent for rapid analogue synthesis and lead optimisation campaigns.

Safe Handling, Storage, and Waste Disposal

Personal protective equipment (PPE): Handle 5-(Benzyloxy)-2,4-dichloropyrimidine in a well-ventilated fume hood. Wear appropriate PPE including nitrile gloves, laboratory coat, and safety glasses. Avoid inhalation of dust or aerosols.

Storage: Store in a tightly sealed container in a cool (recommended 2–8 °C or as specified on the CoA), dry location away from light, heat, and moisture. Keep away from incompatible materials such as strong oxidisers, strong bases, and reactive amines. Check the Certificate of Analysis (CoA) supplied with each lot for confirmed purity and specific storage instructions.

Stability: The compound is expected to be stable under recommended storage conditions. However, prolonged exposure to moisture or light may lead to degradation. Aliquot stock solutions to avoid repeated freeze–thaw cycles if dissolved in organic solvent.

Waste disposal: Dispose of all waste in accordance with applicable local, regional, and national regulations governing halogenated organic compounds. Do not dispose of down the drain. Consult your institutional Environmental Health and Safety (EHS) office for guidance on waste segregation and disposal contracts.

First aid: In case of skin contact, wash thoroughly with soap and water. For eye contact, rinse immediately with copious water for at least 15 minutes and seek medical attention. If inhaled, move to fresh air immediately.